Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Boccia

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 10, 2025
Failure of early interval debulking surgery after standard neoadjuvant chemotherapy: May bevacizumab add something? A large retrospective studyRaffaella Ergasti, Laura Vertechy, Ilary Ruscito, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 28, 2024
Epithelial ovarian cancer and brain metastases: might the <i>BRCA</i> status, PARP inhibitor administration, and surgical treatment impact the survival?Carolina Maria Sassu, Claudia Marchetti, Giorgia Russo, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 10, 2025
Failure of early interval debulking surgery after standard neoadjuvant chemotherapy: May bevacizumab add something? A large retrospective studyRaffaella Ergasti, Laura Vertechy, Ilary Ruscito, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 28, 2024
Epithelial ovarian cancer and brain metastases: might the <i>BRCA</i> status, PARP inhibitor administration, and surgical treatment impact the survival?Carolina Maria Sassu, Claudia Marchetti, Giorgia Russo, et al.
Pageof 3